======= SYS1 ======= == Gene Information == * **Official Symbol**: SYS1 * **Official Name**: SYS1 golgi trafficking protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=90196|90196]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N2H4|Q8N2H4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SYS1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SYS1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/612979|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Involved in protein trafficking. May serve as a receptor for ARFRP1. |SYS1| |Golgi to endosome transport| |protein localization to Golgi apparatus| |Golgi to plasma membrane protein transport| |establishment of protein localization to plasma membrane| |Golgi to plasma membrane transport| |integral component of Golgi membrane| |trans-Golgi network membrane| |vesicle-mediated transport to the plasma membrane| |post-Golgi vesicle-mediated transport| |cytosolic transport| |trans-Golgi network| |protein localization to plasma membrane| |protein localization to cell periphery| |establishment of protein localization to membrane| |Golgi vesicle transport| |protein localization to membrane| |protein localization to organelle| |protein transport| |intracellular transport| |peptide transport| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |establishment of localization in cell| |nitrogen compound transport| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp507|Monensin 0.3μM R08 exp507]]|-2.93| |[[:results:exp34|Rotenone 20μM R00 exp34]]|-2.57| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-2.52| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|-2.45| |[[:results:exp19|Etoposide 1μM R00 exp19]]|-2.39| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.39| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|-2.3| |[[:results:exp114|A-196 10μM R03 exp114]]|-2.27| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-2.25| |[[:results:exp22|MLN-4924 2μM R00 exp22]]|-2.22| |[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|-2| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-1.96| |[[:results:exp401|SNS-032 25μM R07 exp401]]|-1.95| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|-1.92| |[[:results:exp17|DABN 20μM R00 exp17]]|-1.91| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|-1.9| |[[:results:exp31|Rifampicin 1μM R00 exp31]]|-1.85| |[[:results:exp504|MK2206 4μM R08 exp504]]|-1.74| |[[:results:exp126|GSK461364A 0.1μM R03 exp126]]|-1.71| ^Gene^Correlation^ |[[:human genes:v:vps54|VPS54]]|0.45| |[[:human genes:v:vps52|VPS52]]|0.438| |[[:human genes:c:cbwd6|CBWD6]]|0.434| |[[:human genes:c:copb2|COPB2]]|0.428| |[[:human genes:o:osbp|OSBP]]|0.424| |[[:human genes:p:prim1|PRIM1]]|0.41| |[[:human genes:c:cbwd3|CBWD3]]|0.41| |[[:human genes:p:pola1|POLA1]]|0.4| Global Fraction of Cell Lines Where Essential: 669/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|27/28| |blood|23/28| |bone|25/26| |breast|25/33| |central nervous system|55/56| |cervix|4/4| |colorectal|12/17| |esophagus|13/13| |fibroblast|1/1| |gastric|15/16| |kidney|17/21| |liver|19/20| |lung|64/75| |lymphocyte|16/16| |ovary|21/26| |pancreas|22/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|24/24| |soft tissue|8/9| |thyroid|2/2| |upper aerodigestive|20/22| |urinary tract|24/29| |uterus|4/5| == Essentiality in NALM6 == * **Essentiality Rank**: 813 * **Expression level (log2 read counts)**: 3.87 {{:chemogenomics:nalm6 dist.png?nolink |}}